• Home
  • American Association for Cancer Research

AACR 2025


Chicago, IL

American Association for Cancer Research
Explore more Oncology congress materials
Material Type

Results(3)

Oncology
EmpowHER-303: A Phase 3 Study of Zanidatamab vs Trastuzumab With Physician’s Choice of Chemotherapy in Patients With HER2+ Metastatic Breast Cancer Whose Disease Progressed on Trastuzumab Deruxtecan
Author(s): Sara M. Tolaney, Javier Cortes, Erika Hamilton et al.
HERIZON-BTC-302: A Phase 3 Trial of Zanidatamab With Standard-of-Care Therapy vs SOC Alone For First-Line Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced/Metastatic Biliary Tract Cancer
Author(s): James J. Harding, Teresa Macarulla, Xiaotian Wu et al.
Real-World Second-Line Treatment Patterns and Clinical Outcomes in Patients With HER2-Overexpressing Biliary Tract Cancer
Author(s): Richard Kim, Xiaozhou Fan, Javier Sabater et al.